Universe · entity
Rosalind Advisors, Inc.
Institutional manager (13F) · CIK 1622627
13F holdings · as of 2026-03-31 · top 32 · reported portfolio $244M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | DELCATH SYSTEMS, INC. | $31M | 3,300,389 |
| 2 | XERIS BIOPHARMA HOLDINGS INC | $19M | 3,231,700 |
| 3 | FENNEC PHARMACEUTICALS INC | $18M | 2,908,201 |
| 4 | SAVARA INC | $17M | 3,203,721 |
| 5 | VAXCYTE INC | $17M | 290,000 |
| 6 | EYEPOINT PHARMACEUTICALS INC | $13M | 1,036,737 |
| 7 | X4 PHARMACEUTICALS INC | $13M | 3,214,766 |
| 8 | VOR BIOPHARMA INC | $12M | 700,000 |
| 9 | MEDIWOUND LTD | $12M | 749,054 |
| 10 | VERASTEM INC | $11M | 2,138,475 |
| 11 | CELLDEX THERAPEUTICS INC | $10M | 330,000 |
| 12 | BIOCRYST PHARMACEUTICALS INC | $9M | 923,057 |
| 13 | CYBIN INC | $7M | 1,531,814 |
| 14 | CG ONCOLOGY INC | $7M | 100,000 |
| 15 | INSPIREMD INC | $6M | 3,905,743 |
| 16 | ATEA PHARMACEUTICALS INC | $6M | 1,171,855 |
| 17 | PROFOUND MEDICAL CORP | $5M | 828,118 |
| 18 | VIRIDIAN THERAPEUTICS INC | $5M | 250,401 |
| 19 | POLYPID LTD | $3M | 597,926 |
| 20 | MYOMO INC | $3M | 3,847,272 |
| 21 | TALPHERA INC | $3M | 3,353,916 |
| 22 | OVID THERAPEUTICS INC | $2M | 1,107,994 |
| 23 | DEFINIUM THERAPEUTICS INC | $2M | 125,000 |
| 24 | ONKURE THERAPEUTICS INC | $2M | 443,763 |
| 25 | LIPOCINE INC | $2M | 221,616 |
| 26 | NEURAXIS INC | $2M | 286,138 |
| 27 | AVALO THERAPEUTICS INC | $1M | 75,000 |
| 28 | ANNEXON INC | $1M | 200,000 |
| 29 | AQUESTIVE THERAPEUTICS INC | $1M | 250,000 |
| 30 | BIOFRONTERA INC | $942k | 1,163,962 |
| 31 | KURA ONCOLOGY INC | $813k | 100,000 |
| 32 | REGENTIS BIOMATERIALS LTD | $768k | 251,510 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.